{"schema_version":"secwatch.filing_event.v1","accession":"0000950170-25-007314","form_type":"8-K","ticker":"HSCS","cik":"0001468492","company_name":"HeartSciences Inc.","filed_at":"2025-01-21T23:59:59+00:00","discovered_at":"2026-05-14T18:03:03.713754+00:00","generated_at":"2026-05-27T22:03:32.473368+00:00","sec_items":["3.02","5.02","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.45,"calibrated_materiality_score":0.45,"confidence":"high","headline":"HeartSciences grants 117K options to execs and directors at $3.33 strike","bullets":["CEO Andrew Simpson and COO Mark Hilz each receive 45,000 options; CFO Danielle Watson receives 9,000.","Non-employee directors Brian Szymczak, Bruce Brent, and David R. Wells each receive 6,000 options.","All options have exercise price of $3.33 per share; executive options vest over 3 years with 1-year cliff.","Director options vested 1/4 immediately, remainder quarterly; vesting may accelerate on FDA clearance."],"urls":{"canonical":"https://secwatch.observer/filing/0000950170-25-007314","json":"https://secwatch.observer/filing/0000950170-25-007314.json","markdown":"https://secwatch.observer/filing/0000950170-25-007314.md","text":"https://secwatch.observer/filing/0000950170-25-007314.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1468492/000095017025007314/0000950170-25-007314-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1468492/000095017025007314/hscs-20250116.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-27T22:03:32.473368+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}